Brief: Ajanta Pharma launches Voriconazole tablets in U.S.
Nov 7 (Reuters) - Ajanta Pharma Ltd AJPH.NS
* Ajanta pharma usa - launch of voriconazole tablets (50mg,
200mg), a bioequivalent generic version of Vfend into us market
Source text for Eikon: ID:nPn7M88Zqa
Further company coverage: AJPH.NS
((Bangalore.newsroom@thomsonreuters.com ;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility